Fig. 3From: Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional studyPrescribed daily doses of TC (mg/day) at Visit 1 – Efficacy population (n = 774)Back to article page